Gene Expression in Personalized Management of Diseases of Civilization

Dear Colleagues,

This Special Issue, entitled "Gene Expression in Personalized Management of Diseases of Civilisation", delves into the burgeoning field of precision medicine, which tailors treatments for individual patients based on their unique genetic profiles. It highlights how the analysis of gene expression patterns in various diseases of civilisation—such as cancer, diabetes, cardiovascular diseases, and neurodegenerative conditions—can guide more precise and effective therapeutic decisions. By examining the activity levels of specific genes, researchers are uncovering molecular markers that can predict a patient's response to different treatments, paving the way for personalized approaches to disease management.

This Special Issue also explores the critical role of genomic technologies, such as next-generation sequencing and microarray analysis, in unraveling complex gene expression profiles. These advanced methodologies allow clinicians to investigate diseases at the molecular level, enabling the identification of the most appropriate treatment strategies and ultimately improving patient outcomes.

Furthermore, this Special Issue addresses the challenges and future directions in this rapidly evolving field, including the need for robust data integration, biomarker validation, and the development of innovative computational tools for interpreting data. Ultimately, "Gene Expression in Personalized Management of Diseases of Civilisation" underscores the potential of gene expression analysis to revolutionize healthcare, ushering in an era of precision medicine tailored to the genetic makeup of each individual patient across a spectrum of modern diseases.

Dr. Beniamin Oskar Grabarek
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.